Global Ablation Technology Market Growth (Status and Outlook) 2023-2029

Global Ablation Technology Market Growth (Status and Outlook) 2023-2029

Ablation Technologies is the treatment that destroys tumors or unwanted material without affecting other body tissues or organs. Because of poor health or reduced organ function, these techniques are widely used to treat cancer, cardiovascular and other chronic diseases. In the treatment of chronic diseases, medical ablation plays the prime role in the removal or complete destruction of abnormal tissue. Medical ablation can be done without surgery by insertion of the probe or a needle through the skin into the tumor. Ablation refers to a minimally invasive surgical procedure for the destruction or removal of abnormal tissues that can cause life-threatening conditions such as cancer, atrial fibrillation, and others. The most common types of cancers treated by medical ablation are kidney (renal) cancer, liver cancer, and lung cancer.

LPI (LP Information)' newest research report, the “Ablation Technology Industry Forecast” looks at past sales and reviews total world Ablation Technology sales in 2022, providing a comprehensive analysis by region and market sector of projected Ablation Technology sales for 2023 through 2029. With Ablation Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ablation Technology industry.

This Insight Report provides a comprehensive analysis of the global Ablation Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ablation Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ablation Technology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ablation Technology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ablation Technology.

The global Ablation Technology market size is projected to grow from US$ 3916.9 million in 2022 to US$ 7513 million in 2029; it is expected to grow at a CAGR of 9.8% from 2023 to 2029.

Global Ablation Technologies key players include Medtronic, AtriCure, Dornier MedTech, Boston Scientific, AngioDynamics, etc. Global top five manufacturers hold a share about 50%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent. In terms of product, Radiofrequency Ablation is the largest segment, with a share about 55%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Disease, Pain Management, Ophthalmology, Gynecology, Orthopedic Treatment, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Ablation Technology market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Electrical
Ultrasound
Radiation
Radiofrequency

Segmentation by application
Cancer
Cardiovascular
Ophthalmology
Orthopaedics
Urology

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Arthocare
Accuray
Biosense
Corporation
Webster
Smith & Nephew
Varian Medical Systems
Olympus Corporation

Please note: The report will take approximately 2 business days to prepare and deliver.